Covington and Wilson Sonsini have advised Odyssey Therapeutics. Cooley has advised the underwriters. Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on autoimmune and inflammatory diseases,…
Odyssey Therapeutics Announces $304 Million Upsized IPO and Private Placement

























